戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 d by the immunostaining of fibers for VAChT (vesicular acetylcholine transporter).
2 zovesamicol (IBVM), an in vivo marker of the vesicular acetylcholine transporter.
3 we used brain sections immunostained for the vesicular acetylcholine transporter.
4  do not express choline acetyltransferase or vesicular acetylcholine transporter.
5  binding of (123)I-iodobenzovesamicol to the vesicular acetylcholine transporter.
6 ng protein toxin, to an antibody against the vesicular acetylcholine transporter.
7 ensities for [3H]vesamicol, which labels the vesicular acetylcholine transporter.
8 ning confocal microscopy, colocalized in PnO vesicular acetylcholine transporter, a presynaptic marke
9 of wild-type mice, is immunoreactive for the vesicular acetylcholine transporter, a recently identifi
10         Here, we used antibodies against the vesicular acetylcholine transporter and a new stereologi
11 ocytochemically with an antibody against the vesicular acetylcholine transporter and digitally photog
12 tylcholinesterase activities, and binding to vesicular acetylcholine transporter and Na(+)-dependent
13                Human alpha cells express the vesicular acetylcholine transporter and release acetylch
14 s encoding choline acetyltransferase and the vesicular acetylcholine transporter and up-regulated ace
15 ons lacked detectable immunoreactivities for vesicular acetylcholine transporter and vasoactive intes
16 was expressed in a minority of SP, VIP, NPY, vesicular acetylcholine transporter, and calcitonin gene
17             Calcitonin gene-related peptide, vesicular acetylcholine transporter, and tyrosine hydrox
18 8)F]-VAT, a new radiotracer that targets the vesicular acetylcholine transporter as a proxy measure o
19 ed to calculate [123I]-iodobenzovesamicol to vesicular acetylcholine transporter binding potential va
20 y is a robust predictor of regional cerebral vesicular acetylcholine transporter bindings, especially
21                 The septal cells stained for vesicular acetylcholine transporter, but not for ChAT, h
22 is transported into synaptic vesicles by the vesicular acetylcholine transporter encoded by unc-17.
23 ter binding potential value, proportional to vesicular acetylcholine transporter expression.
24 n capture of a vesicle membrane protein, the vesicular acetylcholine transporter, from single vesicle
25 s purpose also carries several copies of the vesicular acetylcholine transporter gene (VAChT), which
26 linergic gene locus, which contains both the vesicular acetylcholine transporter gene and the choline
27  now show that choline acetyltransferase and vesicular acetylcholine transporter homologs are prefere
28                   The human homologue of the vesicular acetylcholine transporter (hVAChT) and the neu
29 ic terminals in the rat spinal cord by using vesicular acetylcholine transporter immunocytochemistry.
30 tions, a significantly greater proportion of vesicular acetylcholine transporter-immunoreactive (VACh
31 rase [ChAT] activity, the number of ChAT and vesicular acetylcholine transporter-immunoreactive neuro
32 forebrain morphometry with the topography of vesicular acetylcholine transporter in a large Parkinson
33 herefore examined expression of ChAT and the vesicular acetylcholine transporter in the embryonic and
34 amicol (FBT), which selectively binds to the vesicular acetylcholine transporter in the presynaptic c
35 ed the presence of cholinergic marker VAChT (vesicular acetylcholine transporter) in the region.
36                               A new class of vesicular acetylcholine transporter inhibitor that incor
37                                 In contrast, vesicular acetylcholine transporter-IR motor axon synaps
38                         PET imaging with the vesicular acetylcholine transporter ligand 18F-F-fluoroe
39 ur ongoing structure-activity studies of the vesicular acetylcholine transporter ligand 2-(4-phenylpi
40 h de novo and established PD cohorts, we use vesicular acetylcholine transporter ligand [(18)F]FEOBV
41 mpound was more potent than the prototypical vesicular acetylcholine transporter ligand vesamicol.
42 l fragment of 1 will not lead to more potent vesicular acetylcholine transporter ligands.
43 as well as, reduced acetylcholinesterase and vesicular acetylcholine transporter mRNA.
44 s displayed moderately high affinity for the vesicular acetylcholine transporter, no compound was mor
45 ualized in brain sections stained for either vesicular acetylcholine transporter or choline acetyltra
46 ry motor neurons, labeled with antibodies to vesicular acetylcholine transporter or substance-P, were
47 ized on the same synaptic vesicles as either vesicular acetylcholine transporter or vesicular monoami
48  cholinergic system integrity as assessed by vesicular acetylcholine transporter PET.
49          [(18) F]-Fluoroethoxybenzovesamicol vesicular acetylcholine transporter positron emission to
50 n addition, dual localization of M2R and the vesicular acetylcholine transporter protein (VAChT), a m
51 ections and does not require the function of vesicular acetylcholine transporter protein.
52                   Molecular imaging of brain vesicular acetylcholine transporter provides a biomarker
53 y and negatively charged residues of the rat vesicular acetylcholine transporter (rVAChT) were studie
54                 Immunohistochemistry for the vesicular acetylcholine transporter showed that choliner
55 on of, and optimize methods to quantify, the vesicular acetylcholine transporter-specific tracer (-)-
56  antibodies to choline acetyltransferase and vesicular acetylcholine transporter to label cholinergic
57 dobenzovesamicol, a SPECT radiotracer of the vesicular acetylcholine transporter, to evaluate in vivo
58 ampal sections were dually immunolabeled for vesicular acetylcholine transporter (VAChT) and ERalpha
59 ract-tracing and immunocytochemistry for the vesicular acetylcholine transporter (VAChT) and for tyro
60 col derivative that binds selectively to the vesicular acetylcholine transporter (VAChT) and has been
61 ampal sections were dually immunolabeled for vesicular acetylcholine transporter (VAChT) and MOR-1 an
62 reveals that CHT-positive vesicles carry the vesicular acetylcholine transporter (VAChT) and synaptic
63  including choline acetyltransferase (ChAT), vesicular acetylcholine transporter (VAChT) and the high
64                            Validation of the vesicular acetylcholine transporter (VAChT) and the neur
65 col is a SPECT radioligand selective for the vesicular acetylcholine transporter (VAChT) and used to
66                             Sequence-related vesicular acetylcholine transporter (VAChT) and vesicula
67 -12) cells stably transfected with the human vesicular acetylcholine transporter (VAChT) cDNA are des
68                          The closely related vesicular acetylcholine transporter (VAChT) contains a s
69 ng with choline acetyltransferase (ChAT) and vesicular acetylcholine transporter (VAChT) immunohistoc
70 ed for the visualization of somatostatin and vesicular acetylcholine transporter (VAChT) immunoreacti
71                  The unc-17 gene encodes the vesicular acetylcholine transporter (VAChT) in Caenorhab
72  the NK1 receptor and either 1) SP or 2) the vesicular acetylcholine transporter (VAchT) in rat NAc.
73 ncoding choline acetyltransferase (ChAT) and vesicular acetylcholine transporter (VAChT) in specific
74 cutive function by genetically targeting the vesicular acetylcholine transporter (VAChT) in the mouse
75 roscopic dual immunolabeling of M2Rs and the vesicular acetylcholine transporter (VAchT) in the MPT o
76 cycle had an effect on the expression of the vesicular acetylcholine transporter (VAChT) in the SCN,
77                PPG(+) neurons do not express vesicular acetylcholine transporter (vAChT) in the VLM (
78  melanocortin-1 receptor (MC-1R) agonist and vesicular acetylcholine transporter (VAChT) inhibitor an
79                                              Vesicular acetylcholine transporter (VAChT) is inhibited
80 identifies dopaminergic neurons, whereas the vesicular acetylcholine transporter (VAchT) is present o
81                                          The vesicular acetylcholine transporter (VAChT) is responsib
82                           In PC12 cells, the vesicular acetylcholine transporter (VAChT) localizes pr
83                                          The vesicular acetylcholine transporter (VAChT) mediates ACh
84                                              Vesicular acetylcholine transporter (VAChT) PET ligands
85 e cyclase-activating peptide (PACAP) and the vesicular acetylcholine transporter (VAChT) revealed tha
86 study indicated that there was an absence of vesicular acetylcholine transporter (VAChT) staining in
87 tudies with an antiserum that recognizes the vesicular acetylcholine transporter (VAChT) suggest, how
88  of antipeptide antiserum raised against the vesicular acetylcholine transporter (VAchT) that is resp
89 obutyric acid (GABA) transporter (VGAT), and vesicular acetylcholine transporter (VAChT) to determine
90 ructures by cholinergic axons expressing the vesicular acetylcholine transporter (VAChT) was also stu
91                                   A putative vesicular acetylcholine transporter (VAChT) was overexpr
92                                          The vesicular acetylcholine transporter (VAChT) was used as
93 for choline acetyltransferase (ChAT) and the vesicular acetylcholine transporter (VAChT) was used to
94 ell line, A123.7, expressing recombinant rat vesicular acetylcholine transporter (VAChT) with radiola
95 unds having high potency and selectivity for vesicular acetylcholine transporter (VAChT), a heteroaro
96 affold Nemacol and show that it inhibits the vesicular acetylcholine transporter (VAChT), a target re
97 (SP), vasoactive intestinal peptide (VIP) or vesicular acetylcholine transporter (VAchT), and their n
98 T2 along with three cholinergic markers: the vesicular acetylcholine transporter (VAChT), the high-af
99 fy selective high-affinity inhibitors of the vesicular acetylcholine transporter (VAChT), we have int
100 sion of choline acetyltransferase (ChAT) and vesicular acetylcholine transporter (VAChT), which are c
101 activity was localized in significantly more vesicular acetylcholine transporter (VAChT)-IR varicosit
102 biopsies were stained for cholinergic marker vesicular acetylcholine transporter (VAChT).
103 line acetyltransferase (ChAT) and a putative vesicular acetylcholine transporter (VAChT).
104  loaded into synaptic vesicles by a specific vesicular acetylcholine transporter (VAChT).
105  12 putative transmembrane domains (TMDs) of vesicular acetylcholine transporter (VAChT).
106  the cytoplasm into synaptic vesicles by the vesicular acetylcholine transporter (VAChT).
107  the acetylcholine (ACh) binding site in the vesicular acetylcholine transporter (VAChT).
108  acetylcholine into synaptic vesicles by the vesicular acetylcholine transporter (VAChT).
109 d and evaluated as potential ligands for the vesicular acetylcholine transporter (VAChT).
110 ChAT), choline transporter 1 (CHT1, SLC5A7), vesicular acetylcholine transporter (VAChT, SLC18A3), an
111 398 in a three-dimensional homology model of vesicular acetylcholine transporter (VAChT, TC 2.A.1.2.1
112               For PET imaging of presynaptic vesicular acetylcholine transporters (VAChT), (-)-(18)F-
113 histochemical markers for cholinergic cells (vesicular acetylcholine transporter [VAChT]), tyrosine h
114 histochemical markers for cholinergic cells (vesicular acetylcholine transporter [VAChT]), tyrosine h
115 ic synapses (75% +/- 14% colocalize with the vesicular acetylcholine transporter; VAChT).
116 bodies to glutamic acid decarboxylase (GAD), vesicular acetylcholine transporter (VAT), or the peptid
117                              And, VACHT, the vesicular acetylcholine transporter, was highly correlat
118                                The levels of vesicular acetylcholine transporter were also decreased
119 ients with SCZ and explored relationships of vesicular acetylcholine transporter with clinical sympto

 
Page Top